Naltrexone, used either alone or together with disulfiram or acamprosate, is associated with a decreased risk of hospitalization due to
Continue reading »
Vertex Announces FDA Approvals of Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor), Symdeko (tezacaftor/ivacaftor and ivacaftor) and Kalydeco (ivacaftor) for Use in People With CF With Certain Rare Mutations
BOSTON–(BUSINESS WIRE)–December 21, 2020 — Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) expanded
Continue reading »
Increase in pleasurable effects of alcohol over time can predict alcohol use disorder
A new study out of the University of Chicago Medicine following young adult drinkers for 10 years has found that
Continue reading »
Thousands risking blindness because they don't use eye drops properly
Thousands of Britons are risking blindness because they do not use their eye drops properly, warn experts It is essential
Continue reading »
WHO Guideline Development Group advises against use of remdesivir for COVID-19
The antiviral drug remdesivir is not suggested for patients admitted to hospital with COVID-19, regardless of how severely ill they
Continue reading »
Smartphone use offers tool to treat multiple sclerosis, other diseases
Monitoring how patients with multiple sclerosis or other degenerative diseases use their smartphones could provide valuable information to help get
Continue reading »
Q&A: Turmeric use in breast cancer treatment
DEAR MAYO CLINIC: I recently was diagnosed with breast cancer, and I will have surgery followed by chemotherapy. A friend
Continue reading »
Aspirin use reduces risk of death in hospitalized patients, new study says
Hospitalized COVID-19 patients who were taking a daily low-dose aspirin to protect against cardiovascular disease had a significantly lower risk
Continue reading »
Rates of e-cigarette and marijuana use not associated with vaping-related lung injuries
Higher rates of e-cigarette and marijuana use in U.S. states did not result in more e-cigarette or vaping-related lung injuries
Continue reading »
Pembrolizumab use supported in advanced melanoma
(HealthDay)—Use of pembrolizumab is supported among patients with advanced melanoma, regardless of BRAF V600E/K mutation status or prior receipt of
Continue reading »